Status:
COMPLETED
Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)
Lead Sponsor:
University of Zurich
Conditions:
Hymenoptera Sting Allergy
Eligibility:
All Genders
5-90 years
Brief Summary
In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Bee and/or Wasp allergic patients treated by SIT
- Exclusion criteria:
- None
Exclusion
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00742794
Start Date
August 1 2008
End Date
August 1 2010
Last Update
August 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zurich, Switzerland